Bank of Montreal Files 424B2 Prospectus

Ticker: BMO · Form: 424B2 · Filed: 2026-04-07T14:50:55-04:00

Sentiment: neutral

Topics: prospectus, securities-offering, financials

Related Tickers: BMO

TL;DR

BMO filed a prospectus (424B2) on 4/7/26. New securities offering incoming.

AI Summary

Bank of Montreal filed a 424B2 prospectus on April 7, 2026, detailing a new offering. The filing, with SEC Accession Number 0001214659-26-004396, pertains to a registration statement related to securities. The company's mailing and business address is 1 First Canadian Place, Toronto, ON M5X 1A1.

Why It Matters

This filing indicates Bank of Montreal is actively managing its capital structure and potentially issuing new securities, which could impact its financial leverage and investor base.

Risk Assessment

Risk Level: low — A 424B2 filing is a standard prospectus supplement and does not inherently indicate increased risk for the company.

Key Numbers

Key Players & Entities

FAQ

What type of securities is Bank of Montreal registering in this 424B2 filing?

The filing is a prospectus supplement (424B2) under Rule 424(b)(2), indicating the registration of securities, but the specific type is not detailed in the provided summary information.

What is the SEC Accession Number for this filing?

The SEC Accession Number for this filing is 0001214659-26-004396.

When was this prospectus filed?

The prospectus was filed on April 7, 2026.

What is the CIK number for Bank of Montreal?

The CIK number for Bank of Montreal is 0000927971.

Where is Bank of Montreal's business address listed in the filing?

Bank of Montreal's business address is listed as 1 First Canadian Place, Toronto, ON M5X 1A1.

Filing Stats: 4,650 words · 19 min read · ~16 pages · Grade level 10 · Accepted 2026-04-07 14:50:55

Key Financial Figures

Filing Documents

Risk Factors

Risk Factors There are important differences between the notes and a conventional debt security. An investment in the notes involves significant risks, including those listed below. You should carefully review the more detailed explanation of risks relating to the notes in the “Risk Factors” sections beginning on page PS-5 of product supplement STOCK ARN-1, page S-2 of the prospectus supplement, and page 9 of the prospectus identified above. We also urge you to consult your investment, legal, tax, accounting, and other advisors before you invest in the notes. Structure-related Risks § Depending on the performance of the Underlying Stock as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal. § The notes do not pay interest, and any return on the notes may be less than the yield you could earn by owning a conventional fixed or floating rate debt security of comparable maturity. § Any positive return on your investment is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the Underlying Stock. § Payments on the notes are subject to our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. If we become insolvent or are unable to pay our obligations, you may lose your entire investment. Valuation and Market-related Risks § Our initial estimated value of the notes is only an estimate, and is based on a number of factors. The public offering price of the notes may exceed our initial estimated value, because costs associated with offering, structuring and hedging the notes are included in the public offering price, but are not included in the estimated value. These costs will include any underwriting discount and selling concessions and the cost of hedging our obligations under the notes through one or more hedge counterparties (wh

View on Read The Filing